Navigation Links
PharMEDium Supports Draft Legislation, Efforts to Strengthen Oversight of the Compounding Industry
Date:4/26/2013

WASHINGTON, April 26, 2013 /PRNewswire/ -- PharMEDium is encouraged by the progress made today by the twelve bipartisan Members of the Senate Health, Education, Labor, and Pensions (HELP) Committee toward assuring the highest level of safety possible for patients who receive sterile compounded preparations. The Senate HELP Committee has produced a detailed and thoughtful Bill which goes a long way toward addressing the complicated but crucial question of how to improve regulatory oversight of this vital sector of the pharmacy industry. 

PharMEDium, the nation's leading provider of sterile admixture preparations for hospitals throughout the country, supports the proposed new category of "compounding manufacturer," federal oversight and inspections of these facilities to applicable cGMP standards. While we recognize this is the beginning of a lengthy legislative process, we encourage those in our industry to join us in supporting these efforts to achieve and maintain the highest quality of safety for users of sterile preparations. PharMEDium has long advocated for increased FDA authority and oversight of the sterile compounding process and looks forward to working with the Committee and Members of Congress on the further development and passage of this important legislation.

Who we are: PharMEDium is one of the nation's leading providers of hospital pharmacy-outsourced, sterile admixture services with centers in four states and thousands of acute care hospital customers nationwide. Our qualified personnel and state-of-the-art centers are registered with the FDA, licensed by states as compounding pharmacies and governed by our own rigorous quality standards. We begin the compounding process with sterile FDA-approved drugs from FDA-approved drug manufacturers. It is our mission to be the preeminent provider of choice for hospital customers and to attain the highest degree of integrity in the compounding of sterile preparations.Contact:

Bob Szafranski Bob.Szafranski@edelman.com312-863-9135 (mobile)312-240-2687 (work)


'/>"/>
SOURCE PharMEDium
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
2. PharMEDium Encourages Swift Action to Strengthen Federal Oversight of Advanced Sterile Compounding
3. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
4. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
5. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
6. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
7. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
8. Ventana Supports World Patient Safety Day, July 25
9. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
10. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
11. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016  Compass Diversified Holdings (NYSE: ... owner of leading middle market businesses, announced today its ... 31, 2016. First Quarter 2016 Highlights ... ("CAD" or "Cash Flow") of $13.6 million for the ... of $15.0 million for the first quarter of 2016; ...
(Date:5/4/2016)... Yissum Research Development Company ... that it had signed an exclusive world-wide licensing and ... novel protein degradation and immunomodulatory drugs for cancer and ... candidates representing first-in-class therapy for hematologic and solid malignancies. ... The novel technology was developed by Yinon ...
(Date:5/4/2016)... 2016 Research and ... Acute Myeloid Leukemia Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... and Competitive Landscape Highlights 2016, provides comprehensive ... Acute Myeloid Leukemia epidemiology, Acute Myeloid Leukemia ...
Breaking Medicine Technology:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... Multiple award ... been family-owned and operated for over 35 years. Maintaining core values of exceptional customer ... their success and made them a leading name in San Diego plumbing, and other ...
(Date:5/6/2016)... ... May 06, 2016 , ... In honor ... education and corporate training, and the National Military Family Association, a nonprofit that ... as the second full-tuition scholarship recipient of 2016. , “Being awarded this ...
(Date:5/6/2016)... ... 2016 , ... “ Crossing Over: Affirmations of Faith in the Midst of ... allowed those holding vigil to glimpse into the supernatural as their lives ended. With ... spiritually and practically gain insight into providing care to terminal patients. , “I ...
(Date:5/5/2016)... ... May 05, 2016 , ... While the practice and profession ... the impact our aging population has on communities and resources. Aging Life Care plays ... and face age-related challenges. , Aging Life Care is a holistic, client-centered approach ...
(Date:5/5/2016)... ... May 05, 2016 , ... Textile Exchange is excited ... for public stakeholder review. The stakeholder review is an important opportunity for interested parties ... and delivers value to the wool industry., The RWS is intended to be a ...
Breaking Medicine News(10 mins):